January 12, 2015

Management Team

C. Paul Plested CEO and Co-Founder

Dr. Plested obtained his PhD in neuroscience from University of Oxford. After several post-doctorates, Dr. Plested turned to consulting and business development, where he established his own successful communication business venture, Noviatrica, where he acted as a consultant to GSK, Mirati, HIT Global, Tactus Scientific and McGill University. Working full-time as CEO of MangoGen, he has successfully developed the company from its original conception to where it is today. Dr. Plested has a broad medical knowledge that includes cardiovascular disease, neuroscience, human parturition, oncology, vaccinology, and parasitology. Dr. Plested has had 16 scientific publications and a patent application.

Dr. Alain Labbe Chief Scientific Officer

Dr. Labbé graduated in Immunology from the University of Toronto. His thesis work was performed in the laboratory of Dr. Christopher J. Paige at the Ontario Cancer Institute where he worked on a model of leukemia. He joined the laboratory of Dr. Don van Meyel as a post-doctoral researcher in the department of Neurology and Neurosurgery at McGill University. He developed his expertise in the fields of genetics and imaging, working on developmental neurobiology. In 2008, Dr. Labbé joined Micropharma Ltd (Montréal) and was instrumental on the design of wound healing medical devices and on probiotic development to treat metabolic diseases. His scientific and personal experiences in biology and engineering are today providing a unique skill set moving MangoGen’s technology forward. He joined MangoGen Pharma as Director of Research and Development in 2015 and he is now CSO.

Professor Satya Prakash President and Co-Founder

Dr. Prakash is a professor of biomedical engineering at McGill University, QC, Canada. Dr. Prakash leads a research team dedicated to the advancement and development of bioengineered delivery systems, including targeted controlled-release, targeted drug systems and cell delivery mechanisms. The goal is to design biotherapeutics that are capable of targeting specific cell types, organs or tissues to treat specific medical conditions. Dr. Prakash has had over 150 scientific publications, and 60 approved/pending patent applications. In 2003, Dr. Prakash co-founded Micropharma, a microbiome company based in Montreal, Canada. As Director of Micropharma, Prakash has taken scientific discovery through and into the commercial world. Dr. Prakash, is a co-inventor of MangoGen’s patented technology.

                                                              From L to R. Dr. Alain Labbe, C. Paul Plested, Professor Satya Prakash